MAP Pharmaceuticals, Inc.

CIK 1401923 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MAP Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 7, 2014SC 13G/A0000053417-14-000101
Feb 7, 2014SC 13G/A0001137774-14-000090
Mar 12, 2013EFFECT9999999995-13-000679
Mar 12, 2013EFFECT9999999995-13-000678
Mar 12, 2013EFFECT9999999995-13-000684
Mar 11, 2013S-8 POS0001193125-13-101178
Mar 11, 2013POS AM0001193125-13-101135
Mar 11, 2013S-8 POS0001193125-13-101193
Mar 11, 2013S-8 POS0001193125-13-101199
Mar 11, 2013S-8 POS0001193125-13-101167
Mar 11, 201315-12B0001193125-13-101213
Mar 11, 2013POS AM0001193125-13-101151
Mar 11, 2013S-8 POS0001193125-13-101182
Mar 11, 2013POS AM0001193125-13-101139
Mar 5, 2013SC 13D/A0000807249-13-000060
Mar 5, 201340001181431-13-014374
Mar 4, 201340001181431-13-014242
Mar 4, 201340001181431-13-014239
Mar 4, 201340001181431-13-014231
Mar 4, 201340001181431-13-014237
Mar 4, 201340001181431-13-014238
Mar 4, 201340001181431-13-014240
Mar 4, 201340001181431-13-014244
Mar 4, 201340001181431-13-014210
Mar 4, 201340001181431-13-014234